Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device (SeQuent® Sirolimus-Coated Balloon) in Patients With Coronary Artery Disease: A Prospective Observational Study

NCT07444957 is registered in ClinicalTrials.gov with Fundación Interhospitalaria para la Investigación Cardiovascular FIC as lead sponsor.

NCT NCT07444957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device (SeQuent® Sirolimus-Coated Balloon) in Patients With Coronary Artery Disease: A Prospective Observational Study
Lead sponsor
Fundación Interhospitalaria para la Investigación Cardiovascular FIC
Phase
Observational
Overall status
Recruiting
Start date
January 5, 2026
Completion date
July 6, 2030
Enrollment
1,118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), drug coated balloon, nstemi - non-st segment elevation myocardial infarction (mi), silent ischemia, st-elevation myocardial infarction, stable angina, unstable angina, nstemi